These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 21254182)

  • 21. Role of the endocannabinoid system in the development of tolerance to alcohol.
    Basavarajappa BS; Hungund BL
    Alcohol Alcohol; 2005; 40(1):15-24. PubMed ID: 15550443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in the understanding of the role of the endocannabinoid system in liver diseases.
    Huang L; Quinn MA; Frampton GA; Golden LE; DeMorrow S
    Dig Liver Dis; 2011 Mar; 43(3):188-93. PubMed ID: 20934397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.
    Basavarajappa BS; Nixon RA; Arancio O
    Mini Rev Med Chem; 2009 Apr; 9(4):448-62. PubMed ID: 19356123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minireview: Endocannabinoids and their receptors as targets for obesity therapy.
    de Kloet AD; Woods SC
    Endocrinology; 2009 Jun; 150(6):2531-6. PubMed ID: 19372200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning?
    Bermudez-Silva FJ; Viveros MP; McPartland JM; Rodriguez de Fonseca F
    Pharmacol Biochem Behav; 2010 Jun; 95(4):375-82. PubMed ID: 20347862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The endocannabinoid system: physiology and pharmacology.
    Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
    Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A role for the endocannabinoid system in hepatic steatosis].
    Valenzuela C; Castillo V; Ronco AM; Aguirre C; Hirsch S; Llanos M
    Rev Med Chil; 2014 Mar; 142(3):353-60. PubMed ID: 25052273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capsaicin affects brain function in a model of hepatic encephalopathy associated with fulminant hepatic failure in mice.
    Avraham Y; Grigoriadis NC; Magen I; Poutahidis T; Vorobiav L; Zolotarev O; Ilan Y; Mechoulam R; Berry EM
    Br J Pharmacol; 2009 Oct; 158(3):896-906. PubMed ID: 19764982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central endocannabinoid signaling regulates hepatic glucose production and systemic lipolysis.
    O'Hare JD; Zielinski E; Cheng B; Scherer T; Buettner C
    Diabetes; 2011 Apr; 60(4):1055-62. PubMed ID: 21447652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation.
    Di Marzo V
    Pharmacol Res; 2009 Aug; 60(2):77-84. PubMed ID: 19559360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Endocannabinoids: therapeutic perspectives in chronic liver diseases].
    Lotersztajn S; Teixeira-Clerc F; Hezode C; Tran van Nhieu J; Deveaux V; Mallat A
    Gastroenterol Clin Biol; 2007 Mar; 31(3):255-8. PubMed ID: 17396081
    [No Abstract]   [Full Text] [Related]  

  • 32. Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver.
    Mallat A; Lotersztajn S
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G9-G12. PubMed ID: 17975129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.
    Pertwee RG
    AAPS J; 2005 Oct; 7(3):E625-54. PubMed ID: 16353941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
    Fride E
    Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis.
    Pandey R; Hegde VL; Singh NP; Hofseth L; Singh U; Ray S; Nagarkatti M; Nagarkatti PS
    Vitam Horm; 2009; 81():487-504. PubMed ID: 19647124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritus.
    Schlosburg JE; Boger DL; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2009 Apr; 329(1):314-23. PubMed ID: 19168707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral metabolic effects of endocannabinoids and cannabinoid receptor blockade.
    Engeli S
    Obes Facts; 2008; 1(1):8-15. PubMed ID: 20054157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid receptor 1 signaling in hepatocytes and stellate cells does not contribute to NAFLD.
    Wang S; Zhu Q; Liang G; Franks T; Boucher M; Bence KK; Lu M; Castorena CM; Zhao S; Elmquist JK; Scherer PE; Horton JD
    J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34499619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases.
    Tam J
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):267-76. PubMed ID: 26280171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoid receptors as therapeutic targets in the management of liver diseases.
    Mallat A; Lotersztajn S
    Drug News Perspect; 2008 Sep; 21(7):363-8. PubMed ID: 19259549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.